Superoxide dismutase and leupeptin prevent delayed reperfusion injury in the rat small intestine during burn shock.
Delayed fluid resuscitation during burn shock is thought to compromise the integrity of gut mucosa and allow enteric bacteria to cross the luminal wall and infect other sterile organ systems. Superoxide dismutase, a free-oxygen radical scavenger; leupeptin, a protease inhibitor; and verapamil, a calcium channel blocker, were studied to evaluate their efficacy in maintaining cellular integrity in the gut of thermally burned rats whose fluid resuscitation had been delayed. Fifty male rats weighting 280 to 320 gm were given a full-thickness scald burn covering 50% total body surface area. Ten received early fluid resuscitation beginning half an hour after burn, and 40 received fluid resuscitation delayed by 6 hours. Those receiving delayed resuscitation were given superoxide dismutase (n = 10), leupeptin (n = 10), verapamil (n = 10), or a placebo of normal saline solution (n = 10) at the time of fluid resuscitation. Ileal mucosa samples were harvested, and adenosine triphosphate, diphosphate, and monophosphate were measured. Adenosine triphosphate, total nucleotides, and energy charge potential were significantly lower in the placebo group without therapy compared with those of the early resuscitation group. Superoxide dismutase and leupeptin therapy prevented this drop in cellular energy. Total water content was significantly increased in the placebo group compared with that of the early resuscitation group; superoxide dismutase was able to prevent this increase. Data indicate that intestinal reperfusion injury in burned rats can be effectively modulated with superoxide dismutase or leupeptin therapy.
Xia
Z F
ZF
Shriners Burns Institute, University of Texas Medical Branch, Galveston 77550, USA.
Hollyoak
M
M
Barrow
R E
RE
He
F
F
Muller
M J
MJ
Herndon
D N
DN
D000244:Adenosine Diphosphate / Q000378:metabolism; D000249:Adenosine Monophosphate / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D002056:Burns / Q000150:complications* / Q000628:therapy; D005440:Fluid Therapy; D007413:Intestinal Mucosa / Q000378:metabolism; D007421:Intestine, Small / Q000098:blood supply* / Q000378:metabolism; D007976:Leupeptins / Q000627:therapeutic use*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D015427:Reperfusion Injury / Q000209:etiology / Q000378:metabolism / Q000517:prevention & control*; D012151:Resuscitation; D012769:Shock / Q000209:etiology / Q000628:therapy*; D013482:Superoxide Dismutase / Q000627:therapeutic use*; D013997:Time Factors; D014700:Verapamil / Q000627:therapeutic use
D007976:Leupeptins; D000249:Adenosine Monophosphate; D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D014700:Verapamil; D013482:Superoxide Dismutase; C032854:leupeptin